methysergide has been researched along with Hypersensitivity, Type III in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ancker, E; Molteno, AC; Straughan, JL | 1 |
Garovoy, MR; Kupor, LR; McPhaul, JJ; Mullins, JD | 1 |
Chused, TM; Steinberg, AD; Tarpley, TM | 1 |
3 other study(ies) available for methysergide and Hypersensitivity, Type III
Article | Year |
---|---|
Rational management of uveitis.
Topics: Child; Chlorpheniramine; Drug Therapy, Combination; Female; Humans; Immune Complex Diseases; Methysergide; Middle Aged; Prednisone; Uveitis | 1976 |
Treatment of autologous immune complex glomerulonephritis with vasoactive amine antagonists.
Topics: Animals; Capillary Permeability; Chlorpheniramine; Cyproheptadine; Disease Models, Animal; Drug Therapy, Combination; Fluorescent Antibody Technique; Glomerulonephritis; Hydroxyzine; Immune Complex Diseases; Immunoglobulin G; Kidney Glomerulus; Male; Methysergide; Rats | 1977 |
Antagonism of vasoactive amines in NZB-W glomerulonephritis. I. Beneficial effect of methysergide.
Topics: Animals; Antibodies, Antinuclear; Autoimmune Diseases; Fluorescent Antibody Technique; Glomerulonephritis; Hybridization, Genetic; Immune Complex Diseases; Methysergide; Mice; Mice, Inbred NZB; Proteinuria | 1973 |